{"id":131,"date":"2022-09-13T11:54:10","date_gmt":"2022-09-13T11:54:10","guid":{"rendered":"https:\/\/admedsol1stg.wpenginepowered.com\/?page_id=131"},"modified":"2026-03-24T11:15:06","modified_gmt":"2026-03-24T11:15:06","slug":"shareholder-analysis","status":"publish","type":"page","link":"https:\/\/admedsol.com\/investor-relations\/shareholder-information\/shareholder-analysis\/","title":{"rendered":"Shareholder Analysis"},"content":{"rendered":"

[et_pb_section fb_built=”1″ module_class=”ams-angle-header white” _builder_version=”4.27.6″ _module_preset=”default” background_image=”https:\/\/admedsol.com\/wp-content\/uploads\/2023\/06\/Shareholder-Analysis.jpg” background_size=”custom” background_image_width=”50%” background_position=”center_right” custom_padding_tablet=”6rem||4rem||false|false” custom_padding_phone=”5rem||4rem||false|false” hover_enabled=”0″ background_last_edited=”on|phone” use_background_color_gradient_tablet=”off” use_background_color_gradient_phone=”on” background_color_gradient_direction_phone=”135deg” background_color_gradient_stops_phone=”#461a46 0%|rgba(119,43,120,0.75) 100%” background_color_gradient_overlays_image_tablet=”on” background_size_tablet=”cover” locked=”off” global_colors_info=”{}” custom_css_before_last_edited=”off|phone” sticky_enabled=”0″][et_pb_row _builder_version=”4.22.2″ _module_preset=”default” custom_margin=”0rem||3.5rem||false|false” custom_margin_tablet=”||0rem||false|false” custom_margin_phone=”||0rem||false|false” custom_margin_last_edited=”on|tablet” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.22.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_code _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Shareholder Information<\/div>\n

<\/p>\n

Shareholder Analysis<\/h1>\n

<\/p>\n

Contact Us <\/i><\/a><\/div>\n

[\/et_pb_code][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ disabled_on=”on|off|off” module_id=”ams-breadcrumb-section” _builder_version=”4.22.2″ _module_preset=”default” background_color=”rgba(255,255,255,0.9)” custom_margin=”-3.5rem||0px||false|false” custom_padding=”1rem||1rem||false|false” custom_padding_tablet=”1rem||1rem||true|false” locked=”off” global_colors_info=”{}”][et_pb_row _builder_version=”4.18.1″ _module_preset=”default” custom_margin=”0px||0px||false|false” custom_padding=”0px||0px||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.18.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_sidebar area=”et_pb_widget_area_1″ module_id=”breadcrumbs” _builder_version=”4.18.1″ _module_preset=”default” custom_margin=”0px||0px||false|false” custom_padding=”0px||0px||false|false” global_colors_info=”{}”][\/et_pb_sidebar][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_row _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_code _builder_version=”4.27.4″ _module_preset=”default” custom_margin=”0px||0rem||false|false” custom_padding=”0px||0px||false|false” global_colors_info=”{}”]<\/p>\n

Corporate Governance Standing Committees<\/h4>\n

As at 30 September 2025, the Company\u2019s issued share capital consists of 219, 380, 303 ordinary shares with a nominal value of 5p each (\u201cOrdinary Shares\u201d), each share having equal voting rights.<\/pee>[\/et_pb_code][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ module_class=”ams-bg-light-blue” _builder_version=”4.27.4″ _module_preset=”default” custom_css_main_element=”background-color: var(–ams-interface-3);” global_colors_info=”{}”][et_pb_row _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_code _builder_version=”4.27.5″ _module_preset=”default” custom_margin=”0px||0px||false|false” custom_padding=”0px||0px||false|false” global_colors_info=”{}”]<\/p>\n

<\/p>\n <\/p>\n <\/p>\n <\/p>\n <\/p>\n <\/p>\n <\/p>\n <\/p>\n <\/p>\n
Shareholders<\/th>\n

<\/p>\n

30-September-2025<\/th>\n

<\/p>\n

% IC<\/th>\n

<\/tr>\n

<\/p>\n

Octopus Investments Limited<\/td>\n

<\/p>\n

24,374,469<\/td>\n

<\/p>\n

11.11%<\/td>\n

<\/tr>\n

<\/p>\n

Rathbone plc<\/td>\n

<\/p>\n

18,681,034<\/td>\n

<\/p>\n

8.52%<\/td>\n

<\/tr>\n

<\/p>\n

Canaccord Genuity Group Inc<\/td>\n

<\/p>\n

15,510,490<\/td>\n

<\/p>\n

7.07%<\/td>\n

<\/tr>\n

<\/p>\n

Briarwood Chase Mgt<\/td>\n

<\/p>\n

11,007,708<\/td>\n

<\/p>\n

5.02%<\/td>\n

<\/tr>\n

<\/p>\n

Charles Stanley Group<\/td>\n

<\/p>\n

9,936,094<\/td>\n

<\/p>\n

4.53%<\/td>\n

<\/tr>\n

<\/p>\n

Blackrock Inc<\/td>\n

<\/p>\n

7,604,595<\/td>\n

<\/p>\n

3.47%<\/td>\n

<\/tr>\n

<\/table>\n

<\/div>\n

[\/et_pb_code][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_row _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_code _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]In accordance with the AIM Rules (Rule 26), insofar as the Company is aware as at 30 September, the percentage of the Company\u2019s issued share capital that is not in public hands is 13.75%. This percentage consists of the holdings of the directors\u2019 beneficial holdings, the holdings of the AMS Trustee Company in respect of the Company\u2019s Share Incentive Plan (SIP), and the Company\u2019s substantial shareholders. The Company\u2019s free float is 86.25%.<\/pee> Any corporate shareholders who wish to contact AMS, or provide information on their shareholding, can send an email to companysecretary@admedsol.com<\/a>.<\/pee>[\/et_pb_code][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

As at 29 December 2023, the Company\u2019s issued share capital consists of 217, 328, 664 ordinary shares with a nominal value of 5p each (\u201cOrdinary Shares\u201d), each share having equal voting rights.<\/p>\n","protected":false},"author":4,"featured_media":7941,"parent":127,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"page_collections":[],"class_list":["post-131","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"\nShareholder Analysis - Advanced Medical Solutions<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/admedsol.com\/investor-relations\/shareholder-information\/shareholder-analysis\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Shareholder Analysis\" \/>\n<meta property=\"og:description\" content=\"As at 29 December 2023, the Company\u2019s issued share capital consists of 217, 328, 664 ordinary shares with a nominal value of 5p each (\u201cOrdinary Shares\u201d), each share having equal voting rights.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/admedsol.com\/investor-relations\/shareholder-information\/shareholder-analysis\/\" \/>\n<meta property=\"og:site_name\" content=\"Advanced Medical Solutions\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-24T11:15:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/admedsol.com\/wp-content\/uploads\/2024\/01\/ams-logo-on-white.webp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/admedsol.com\\\/investor-relations\\\/shareholder-information\\\/shareholder-analysis\\\/\",\"url\":\"https:\\\/\\\/admedsol.com\\\/investor-relations\\\/shareholder-information\\\/shareholder-analysis\\\/\",\"name\":\"Shareholder Analysis - Advanced Medical Solutions\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/admedsol.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/admedsol.com\\\/investor-relations\\\/shareholder-information\\\/shareholder-analysis\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/admedsol.com\\\/investor-relations\\\/shareholder-information\\\/shareholder-analysis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/admedsol.com\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/ams-logo-on-white.webp\",\"datePublished\":\"2022-09-13T11:54:10+00:00\",\"dateModified\":\"2026-03-24T11:15:06+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/admedsol.com\\\/investor-relations\\\/shareholder-information\\\/shareholder-analysis\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/admedsol.com\\\/investor-relations\\\/shareholder-information\\\/shareholder-analysis\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/admedsol.com\\\/investor-relations\\\/shareholder-information\\\/shareholder-analysis\\\/#primaryimage\",\"url\":\"https:\\\/\\\/admedsol.com\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/ams-logo-on-white.webp\",\"contentUrl\":\"https:\\\/\\\/admedsol.com\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/ams-logo-on-white.webp\",\"width\":1200,\"height\":845},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/admedsol.com\\\/investor-relations\\\/shareholder-information\\\/shareholder-analysis\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/admedsol.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Investor Relations\",\"item\":\"https:\\\/\\\/admedsol.com\\\/investor-relations\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Shareholder Information\",\"item\":\"https:\\\/\\\/admedsol.com\\\/investor-relations\\\/shareholder-information\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Shareholder Analysis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/admedsol.com\\\/#website\",\"url\":\"https:\\\/\\\/admedsol.com\\\/\",\"name\":\"Advanced Medical Solutions\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/admedsol.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/admedsol.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/admedsol.com\\\/#organization\",\"name\":\"Advanced Medical Solutions\",\"url\":\"https:\\\/\\\/admedsol.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/admedsol.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/admedsol.com\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/ams-logo-on-white.webp\",\"contentUrl\":\"https:\\\/\\\/admedsol.com\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/ams-logo-on-white.webp\",\"width\":1200,\"height\":845,\"caption\":\"Advanced Medical Solutions\"},\"image\":{\"@id\":\"https:\\\/\\\/admedsol.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/advanced-medical-solutions\\\/\",\"https:\\\/\\\/uk.linkedin.com\\\/showcase\\\/advanced-medical-solutions-surgical\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/showcase\\\/advanced-medical-solutions-woundcare\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Shareholder Analysis - Advanced Medical Solutions","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/admedsol.com\/investor-relations\/shareholder-information\/shareholder-analysis\/","og_locale":"en_US","og_type":"article","og_title":"Shareholder Analysis","og_description":"As at 29 December 2023, the Company\u2019s issued share capital consists of 217, 328, 664 ordinary shares with a nominal value of 5p each (\u201cOrdinary Shares\u201d), each share having equal voting rights.","og_url":"https:\/\/admedsol.com\/investor-relations\/shareholder-information\/shareholder-analysis\/","og_site_name":"Advanced Medical Solutions","article_modified_time":"2026-03-24T11:15:06+00:00","og_image":[{"url":"https:\/\/admedsol.com\/wp-content\/uploads\/2024\/01\/ams-logo-on-white.webp","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/admedsol.com\/investor-relations\/shareholder-information\/shareholder-analysis\/","url":"https:\/\/admedsol.com\/investor-relations\/shareholder-information\/shareholder-analysis\/","name":"Shareholder Analysis - Advanced Medical Solutions","isPartOf":{"@id":"https:\/\/admedsol.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/admedsol.com\/investor-relations\/shareholder-information\/shareholder-analysis\/#primaryimage"},"image":{"@id":"https:\/\/admedsol.com\/investor-relations\/shareholder-information\/shareholder-analysis\/#primaryimage"},"thumbnailUrl":"https:\/\/admedsol.com\/wp-content\/uploads\/2024\/01\/ams-logo-on-white.webp","datePublished":"2022-09-13T11:54:10+00:00","dateModified":"2026-03-24T11:15:06+00:00","breadcrumb":{"@id":"https:\/\/admedsol.com\/investor-relations\/shareholder-information\/shareholder-analysis\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/admedsol.com\/investor-relations\/shareholder-information\/shareholder-analysis\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/admedsol.com\/investor-relations\/shareholder-information\/shareholder-analysis\/#primaryimage","url":"https:\/\/admedsol.com\/wp-content\/uploads\/2024\/01\/ams-logo-on-white.webp","contentUrl":"https:\/\/admedsol.com\/wp-content\/uploads\/2024\/01\/ams-logo-on-white.webp","width":1200,"height":845},{"@type":"BreadcrumbList","@id":"https:\/\/admedsol.com\/investor-relations\/shareholder-information\/shareholder-analysis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/admedsol.com\/"},{"@type":"ListItem","position":2,"name":"Investor Relations","item":"https:\/\/admedsol.com\/investor-relations\/"},{"@type":"ListItem","position":3,"name":"Shareholder Information","item":"https:\/\/admedsol.com\/investor-relations\/shareholder-information\/"},{"@type":"ListItem","position":4,"name":"Shareholder Analysis"}]},{"@type":"WebSite","@id":"https:\/\/admedsol.com\/#website","url":"https:\/\/admedsol.com\/","name":"Advanced Medical Solutions","description":"","publisher":{"@id":"https:\/\/admedsol.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/admedsol.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/admedsol.com\/#organization","name":"Advanced Medical Solutions","url":"https:\/\/admedsol.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/admedsol.com\/#\/schema\/logo\/image\/","url":"https:\/\/admedsol.com\/wp-content\/uploads\/2024\/01\/ams-logo-on-white.webp","contentUrl":"https:\/\/admedsol.com\/wp-content\/uploads\/2024\/01\/ams-logo-on-white.webp","width":1200,"height":845,"caption":"Advanced Medical Solutions"},"image":{"@id":"https:\/\/admedsol.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/advanced-medical-solutions\/","https:\/\/uk.linkedin.com\/showcase\/advanced-medical-solutions-surgical\/","https:\/\/www.linkedin.com\/showcase\/advanced-medical-solutions-woundcare\/"]}]}},"_links":{"self":[{"href":"https:\/\/admedsol.com\/wp-json\/wp\/v2\/pages\/131","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/admedsol.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/admedsol.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/admedsol.com\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/admedsol.com\/wp-json\/wp\/v2\/comments?post=131"}],"version-history":[{"count":0,"href":"https:\/\/admedsol.com\/wp-json\/wp\/v2\/pages\/131\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/admedsol.com\/wp-json\/wp\/v2\/pages\/127"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/admedsol.com\/wp-json\/wp\/v2\/media\/7941"}],"wp:attachment":[{"href":"https:\/\/admedsol.com\/wp-json\/wp\/v2\/media?parent=131"}],"wp:term":[{"taxonomy":"page_collections","embeddable":true,"href":"https:\/\/admedsol.com\/wp-json\/wp\/v2\/page_collections?post=131"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}